Mrv1909 11101919232D 7 6 0 0 0 0 999 V2000 1.2375 1.0717 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.4125 1.0717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.3572 0.0000 Sb 0 0 0 0 0 0 0 0 0 0 0 0 0.4125 -0.3572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -1.0717 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 -0.8250 0.3572 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2375 1.0717 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 1 0 0 0 0 3 6 1 0 0 0 0 6 7 1 0 0 0 0 M END > DB02453 > drugbank > [H]O[Sb](O[H])O[H] > InChI=1S/3H2O.Sb/h3*1H2;/q;;;+3/p-3 > SZOADBKOANDULT-UHFFFAOYSA-K > H3O3Sb > 172.78 > 171.912037006 > 3 > 7 > 5.761380252946589 > 1 > 3 > 0 > 0 > stiborous acid > -1.6029999999999993 > 0 > 0 > 0 > 18.366767893368426 > 18.366767893368426 > -0.849054468720988 > 60.69 > 7.6937999999999995 > 0 > 1 > [(2R,3R,4S,5S)-3,4-dihydroxy-5-{4-oxo-1H,5H-pyrrolo[3,2-d]pyrimidin-7-yl}pyrrolidin-2-yl]methoxyphosphonic acid > 0 > DB02453 > EXPT02857 > experimental > Antimonous acid > Stiborous acid; Trihydroxyantimonite(III) $$$$